Signature Search Polestar: a comprehensive drug repurposing method evaluation assistant for customized oncogenic signature
Bioinformatics · 2024
DOI: 10.1093/bioinformatics/btae536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2024. Verfasst von Jinbo Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Drug Repositioning, Antineoplastic Agents, Software. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Summary The burgeoning high-throughput technologies have led to a significant surge in the scale of pharmacotranscriptomic datasets, especially for oncology. Signature search methods (SSMs), utilizing oncogenic signatures formed by differentially expressed genes through sequencing, have been instrumental in anti-cancer drug screening and identifying mechanisms of action without relying on prior knowledge. However, various studies have found that different SSMs exhibit varying performance across pharmacotranscriptomic datasets. In addition, the size of the oncogenic signature can also significantly impact the result of drug repurposing. Therefore, finding the optimal SSMs and customized oncogenic signature for a specific disease remains a challenge. To address this, we introduce Signature Search Polestar (SSP), a webserver integrating the largest pharmacotranscriptomic datasets of anti-cancer drugs from LINCS L1000 with five state-of-the-art SSMs (XSum, CMap, GSEA, ZhangScore, XCos). SSP provides three main modules: Benchmark, Robustness, and Application. Benchmark uses two indices, Area Under the Curve and Enrichment Score, based on drug annotations to evaluate SSMs at different oncogenic signature sizes. Robustness, applicable when drug annotations are insufficient, uses a performance score based on drug self-retrieval for evaluation. Application provides three screening strategies, single method, SS_all, and SS_cross, allowing users to freely utilize optimal SSMs with tailored oncogenic signature for drug repurposing. Availability and implementation SSP is free at https://web.biotcm.net/SSP/. The current version of SSP is archived in https://doi.org/10.6084/m9.figshare.26524741.v1, allowing users to directly use or customize their own SSP webserver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
- Department of Pharmacy, Tianjin Rehabilitation Center of Joint Logistics Support Force, Tianjin 300110, China.
- Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
- Department of Clinical Nutrition, Tianjin Rehabilitation Center of Joint Logistics Support Force, Tianjin 300110, China.
- Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai 264005, China.
ORCID-Profile: Jinbo Zhang, Saisai Tian
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Zhang, J., Yuan, S., Cao, W., Jiang, X., Yang, C., Jiang, C., Liu, R., Yang, W., & Tian, S. (2024). Signature Search Polestar: a comprehensive drug repurposing method evaluation assistant for customized oncogenic signature. Bioinformatics. https://doi.org/10.1093/bioinformatics/btae536
Vancouver
Zhang J, Yuan S, Cao W, Jiang X, Yang C, Jiang C, et al. Signature Search Polestar: a comprehensive drug repurposing method evaluation assistant for customized oncogenic signature. Bioinformatics. 2024. doi:10.1093/bioinformatics/btae536
BibTeX
@article{Zhang2024,
author = {Zhang, Jinbo and Yuan, Shunling and Cao, Wen and Jiang, Xianrui and Yang, Cheng and Jiang, Chenchao and Liu, Runhui and Yang, Wei and Tian, Saisai},
title = {Signature Search Polestar: a comprehensive drug repurposing method evaluation assistant for customized oncogenic signature},
journal = {Bioinformatics},
year = {2024},
doi = {10.1093/bioinformatics/btae536}
}
EUVIMED